- Home
- CADL vs GPRK Comparison
CADL vs GPRK Comparison
Compare CADL & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GPRK
- Stock Information
- Founded
- CADL 1999
- GPRK 2002
- Country
- CADL United States
- GPRK Colombia
- Employees
- CADL N/A
- GPRK N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GPRK Oil & Gas Production
- Sector
- CADL Health Care
- GPRK Energy
- Exchange
- CADL Nasdaq
- GPRK Nasdaq
- Market Cap
- CADL 339.8M
- GPRK 335.7M
- IPO Year
- CADL 2021
- GPRK N/A
- Fundamental
- Price
- CADL $5.64
- GPRK $8.09
- Analyst Decision
- CADL Strong Buy
- GPRK Buy
- Analyst Count
- CADL 7
- GPRK 1
- Target Price
- CADL $19.57
- GPRK $11.00
- AVG Volume (30 Days)
- CADL 841.7K
- GPRK 1.7M
- Earning Date
- CADL 11-14-2025
- GPRK 11-05-2025
- Dividend Yield
- CADL N/A
- GPRK 7.16%
- EPS Growth
- CADL N/A
- GPRK N/A
- EPS
- CADL N/A
- GPRK 0.81
- Revenue
- CADL N/A
- GPRK $560,354,000.00
- Revenue This Year
- CADL N/A
- GPRK N/A
- Revenue Next Year
- CADL N/A
- GPRK N/A
- P/E Ratio
- CADL N/A
- GPRK $8.19
- Revenue Growth
- CADL N/A
- GPRK N/A
- 52 Week Low
- CADL $3.79
- GPRK $5.66
- 52 Week High
- CADL $14.60
- GPRK $11.72
- Technical
- Relative Strength Index (RSI)
- CADL 51.71
- GPRK 67.81
- Support Level
- CADL $5.35
- GPRK $6.52
- Resistance Level
- CADL $5.80
- GPRK $8.27
- Average True Range (ATR)
- CADL 0.37
- GPRK 0.32
- MACD
- CADL -0.01
- GPRK 0.18
- Stochastic Oscillator
- CADL 42.40
- GPRK 92.86
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.